I. Lavi
Impact in
- Urology top 5%
- Urinary Bladder and Prostate Research
Papers in
-
- Urinary Tract Infections Management 3
-
- Rheumatoid Arthritis Research and Therapies 3
- Spondyloarthritis Studies and Treatments 3
- Co-authors
- Raanan Raz (6 shared papers)Naiel Bisharat (2 shared papers)Hussam Omari (1 shared paper)Reuven Mader (2 shared papers)Gad Rennert (3 shared papers)Naomi Gronich (2 shared papers)Yoram Kennes (2 shared papers)Bibiana Chazan (2 shared papers)
- Journals
- Annals of the Rheumatic Diseases (3 papers)Journal of the European Academy of Dermatology and Venereology (2 papers)Infection (2 papers)Dermatology (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- IsraelUnited StatesCzechia
In The Last Decade
I. Lavi
22 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 107
- Urology 139
- Applied Microbiology and Biotechnology 38
- Hematology 138
- Rheumatology 142
- Molecular Medicine 45
Countries citing papers authored by I. Lavi
This map shows the geographic impact of I. Lavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Lavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Lavi more than expected).
Fields of papers citing papers by I. Lavi
This network shows the impact of papers produced by I. Lavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Lavi. The network helps show where I. Lavi may publish in the future.
Co-authors
The 25 scholars most cited alongside I. Lavi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 330 | |
| 2 | 2002 | 170 | |
| 3 | 2011 | 83 | |
| 4 | 2008 | 74 | |
| 5 | Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease. | 1999 | 71 |
| 6 | 2003 | 57 | |
| 7 | 2001 | 45 | |
| 8 | 2001 | 40 | |
| 9 | 2009 | 31 | |
| 10 | 2005 | 30 | |
| 11 | 2017 | 23 | |
| 12 | 2010 | 23 | |
| 13 | Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel. | 2000 | 23 |
| 14 | 2011 | 21 | |
| 15 | 2008 | 13 | |
| 16 | 2014 | 13 | |
| 17 | 2000 | 12 | |
| 18 | 2002 | 11 | |
| 19 | 2024 | 2 | |
| 20 | 2018 | 1 |
About I. Lavi
I. Lavi is a scholar working on Epidemiology, Rheumatology, Oncology, Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology and Child Health, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Urinary Tract Infections Management (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Spondyloarthritis Studies and Treatments (3 papers), Urinary Bladder and Prostate Research (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Pediatric Urology and Nephrology Studies (2 papers) and Antibiotic Use and Resistance (2 papers). The work is most often cited by research in Urology (139 citations), Applied Microbiology and Biotechnology (38 citations), Hematology (138 citations), Rheumatology (142 citations) and Molecular Medicine (45 citations). I. Lavi has collaborated with scholars based in Israel, United States and Czechia. Frequent co-authors include Raanan Raz, Naiel Bisharat, Hussam Omari, Reuven Mader, Gad Rennert, Naomi Gronich, Yoram Kennes, Bibiana Chazan, Raul Colodner and M. Dan. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of the European Academy of Dermatology and Venereology, Infection, Dermatology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.